MSI-H CANCER

Clinical trials for MSI-H CANCER explained in plain language.

Never miss a new study

Get alerted when new MSI-H CANCER trials appear

Sign up with your email to follow new studies for MSI-H CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

New drug combo shows promise in Hard-to-Treat cancers

Disease control Ongoing

This early-phase study tests an experimental drug called DECOY20, given alone or with another drug (tislelizumab), in about 120 adults with advanced solid tumors like liver, colorectal, pancreatic, lung, head and neck, bladder, or MSI-high cancers. The main goals are to check saf…

Matched conditions: MSI-H CANCER

Phase: PHASE1, PHASE2 • Sponsor: Indaptus Therapeutics, Inc • Aim: Disease control

Last updated May 17, 2026 04:15 UTC

MSI-H CANCER

Get alerted when new MSI-H CANCER trials appear

New drug combo shows promise in Hard-to-Treat cancers